• Kyodo


A drugmaker was ordered Tuesday to suspend its business for 116 days, the longest such order ever imposed on a pharmaceutical company in the country, after systematically making up fictitious production records on nearly 80% of its 500 products.

The order for Kobayashi Kako Co. will be effective starting Wednesday through June 5, said the Fukui Prefectural Government, which authorizes the generic drugmaker in Awara to produce and sell medicine. The company was also found to have skipped pre-shipment quality tests for some products since the late 1970s and forged results, among other legal violations.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.